You are here: Industry Insights > Market News > Pfizer and Moderna raise prices for its COVID-19 vaccines in EU

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Small dust filter

HUMIDIFIER FILTER

Oil fume adsorption filter

Pfizer and Moderna raise prices for its COVID-19 vaccines in EU

firstwordpharmaAugust 02, 2021

Tag: Pfizer , Moderna , COVID-19 Vaccines

Favorites

According to the Financial Times, Pfizer and Moderna have raised the prices of their COVID-19 vaccines in their latest supply contracts with the EU, as reported Sunday in Investing.com.

Pfizer and Moderna raise prices for its COVID-19 vaccines in EU

The newspaper, citing the contracts, suggested that the new price for Pfizer's vaccine is €19.50, up from €15.50 previously, while Moderna's is priced at $25.50 a dose, up from about €19.00 ($22.60).

However, the Financial Times, citing an official close to the matter, noted that the cost of Moderna's product is lower than the previously-agreed price of $28.50 per dose because the order had grown.

Previous:First batches of the Sputnik V vaccine produced in Uzbekistan by Jurabek Laboratories

Next:Taiwan, China starts study on efficacy of mixing AZ, Moderna COVID vaccines

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Pfizer and Moderna raise prices for its COVID-19 vaccines in EU | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

Pfizer and Moderna raise prices for its COVID-19 vaccines in EU

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may like
More>>

Pfizer and Moderna raise prices for its COVID-19 vaccines in EU

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>